New Japan Price Cut Push Has Industry Worried
Executive Summary
Industry groups in Japan have reacted swiftly and strongly to planned government discussions on changes to drug pricing policies, warning that the adoption of annual price cuts would "undo all the policy achievements" of the past few years.
You may also be interested in...
Japan Ups Generic Use Target
Japan's government has released a new "road map" for the development of the generic drug sector, setting an ambitious new five-year target for such products to reflect faster than expected sales expansion following recent policy changes.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: novel BMS drug shows promise in IPF; Novo’s oral semaglutide compares well with injectable in weight loss; Teva looks to innovative brands to return to growth; US setback for Intercept’s NASH drug; and India’s improving environment for clinical trials.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: US FTC takes action on Amgen’s Horizon deal; Hassan and Jimenez share their CEO experiences; Novartis lays out Cosentyx plans; generally strong fiscal year for Japan’s pharma firms; and new Tagrisso data lift AstraZeneca.